Semi-Annual Consolidated Statement Of Income

Chiome Bioscience Inc. - Filing #7312329

Concept 2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2024-01-01 to
2024-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
2023-01-01 to
2023-06-30
Semi-annual consolidated statement of income
Statement of income
Net sales
263,728,000 JPY
263,728,000 JPY
263,728,000 JPY
JPY
JPY
358,889,000 JPY
358,889,000 JPY
JPY
JPY
358,889,000 JPY
Cost of sales
128,970,000 JPY
150,211,000 JPY
Gross profit (loss)
134,758,000 JPY
208,677,000 JPY
Ordinary profit (loss)
-563,345,000 JPY
-662,139,000 JPY
Extraordinary income
1,302,000 JPY
1,003,000 JPY
Selling, general and administrative expenses
Selling, general and administrative expenses
715,894,000 JPY
867,926,000 JPY
Extraordinary losses
JPY
14,000 JPY
Profit (loss) before income taxes
-562,043,000 JPY
-661,150,000 JPY
Operating profit (loss)
134,758,000 JPY
-581,136,000 JPY
-312,059,000 JPY
-446,817,000 JPY
-269,077,000 JPY
208,677,000 JPY
-393,223,000 JPY
-601,900,000 JPY
-266,026,000 JPY
-659,249,000 JPY
Income taxes - current
1,915,000 JPY
2,505,000 JPY
Non-operating income
Interest income
20,000 JPY
10,000 JPY
Non-operating income
21,077,000 JPY
424,000 JPY
Non-operating expenses
Interest expenses
1,282,000 JPY
910,000 JPY
Non-operating expenses
3,286,000 JPY
3,314,000 JPY
Income taxes
1,915,000 JPY
2,505,000 JPY
Profit (loss)
-563,958,000 JPY
-663,655,000 JPY
Extraordinary income
Gain on sale of non-current assets
JPY
73,000 JPY
Extraordinary losses
Loss on sale of non-current assets
JPY
14,000 JPY

Talk to a Data Expert

Have a question? We'll get back to you promptly.